A novel explanation for the cause of atrial fibrillation seen in atherosclerotic coronary artery disease: "Downstream inflammation" hypothesis

Medical Hypotheses

Volumn 74, Issue 4, 2010, Pages 665-667

  Güvenç, Tolga Sinan ^a   Ilhan, Erkan ^a   Hasdemir, Hakan ^a   Satilmiş, Seçkin ^a   Alper, Ahmet Taha ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY CELL; PROTEIN BLOOD LEVEL;

ARRHYTHMIAS, CARDIAC; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; CORONARY ARTERY DISEASE; CORONARY DISEASE; HEART ATRIA; HYPERTENSION; INFLAMMATION; RETROSPECTIVE STUDIES;

EID: 77649339816     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.11.010     Document Type: Article

References (22)

1. Feinberg W.M., Blackshear J.L., Laupacis A., Kronmal R., and Hart R.G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 13 155 (1995) 469-473
2. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., and Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 98 (1995) 476-484
3. Francis G.S. Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. Am J Cardiol 57 (1986) 3B-7B
4. Davidson E., Weinberger I., Rotenberg Z., Fuchs J., and Agmon J. Atrial fibrillation. Cause and time of onset. Arch Intern Med 149 (1989) 457-459
5. Vaziri S.M., Larson M.G., Benjamin E.J., and Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham heart study. Circulation 89 (1994) 724-730
6. Woeber K.A. Thyrotoxicosis and the heart. N Engl J Med 327 (1992) 94-98
7. Ettinger P.O., Wu C.F., De La Cruz Jr. C., Weisse A.B., Ahmed S.S., and Regan T.J. Arrhythmias and the "holiday heart". Alcohol associated cardiac rhythm disorders. Am Heart J 95 (1978) 555
8. Darbar D., Herron K.J., Ballew J.D., Jahangir A., Gersh B.J., Shen W.K., et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 41 (2003) 2185-2192
9. Chen Y.H., Xu S.J., Bendahhou S., Wang X.L., Wang Y., Xu W.Y., et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299 (2003) 251-254
10. Paoletti R., Gotto Jr. A.M., and Hajjar D.P. Inflammation in atherosclerosis and implications for therapy. Circulation 109 (2004) III20-III26
11. Zouridakis E., Avanzas P., Arroyo-Espliguero R., Fredericks S., and Kaski J.C. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 110 (2004) 1747-1753
12. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
13. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon RO 3r., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499
14. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886
15. Yao S.Y., Chu J.M., Chen K.P., Tang M., Fang P.H., Wang F.Z., et al. Inflammation in lone atrial fibrillation. Clin Cardiol 32 (2009) 94-98
16. Chen M.C., Chang J.P., Liu W.H., Yang C.H., Chen Y.L., Tsai T.H., et al. Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. Am J Cardiol 1 102 (2008) 861-865
17. Liberthson R.R., Salisbury K.W., Hutter Jr. A.M., and DeSanctis R.W. Atrial tachyarrhythmias in acute myocardial infarction. Am J Med 60 (1976) 956-960
18. Prystowsky E.N., and Waldo A.L. Atrial fibrillation, atrial flutter and atrial tachycardia. In: Fuster V., O'Rourke R., Walsh R., and Poole-Wilson P. (Eds). Hurst's the heart. 12th ed. (2008), McGraw-Hill, New York 973-976
19. Heeringa J., van der Kuip D.A., Hofman A., Kors J.A., van Rooij F.J., Lip G.Y., et al. Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med 26 167 (2007) 382-387
20. Young-Xu Y., Jabbour S., Goldberg R., Blatt C.M., Graboys T., Bilchik B., et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92 (2003) 1979-1983
21. Hadi H.A., Mahmeed W.A., Suwaidi J.A., and Ellahham S. Pleiotropic effects of statins in atrial fibrillation patients: the evidence. Vasc Health Risk Manag 5 (2009) 533-551
22. Cameron A., Schwartz M.J., Kronmal R.A., and Kosinski A.S. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 61 (1988) 714-717